Swindon, United Kingdom

Leslie A Thelwall

This inventor holds 1 USPTO granted patent. Top assignee: Talres Development (n.a.) N.v.. Active years: 1981.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leslie A Thelwall: Innovator in Sugar Acetals

Introduction

Leslie A Thelwall is a notable inventor based in Swindon, GB. She has made significant contributions to the field of chemistry, particularly in the development of novel sugar acetals. Her innovative work has led to advancements in the preparation and use of these compounds.

Latest Patents

Leslie A Thelwall holds a patent for "Sugar acetals, their preparation and use." This patent describes the creation of novel sugar acetals derived from 1,4-linked reducing disaccharides through a new exchange acetalation process that omits the use of solvents. The sugar acetals produced have free hydroxy groups on the ring, which can be converted into various substituents, such as chlorodeoxy or fatty acid acyl. After deprotection, the corresponding derivative of the initial disaccharide is obtained. This innovative approach showcases her expertise in the field.

Career Highlights

Leslie A Thelwall is associated with Talres Development N.V., where she continues to contribute to research and development in her area of expertise. Her work has garnered attention for its potential applications in various industries.

Collaborations

Throughout her career, Leslie has collaborated with notable colleagues, including Leslie Hough and Anthony C Richardson. These partnerships have further enriched her research and innovation efforts.

Conclusion

Leslie A Thelwall is a pioneering inventor whose work in sugar acetals has opened new avenues in chemical research. Her contributions are significant and continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…